Febuxostat Impurity 47 | CAS 2407762-02-9 - Request Quote
Febuxostat Impurity 47
| SZ CAT No: | SZ-F010083 |
| CAS No | 2407762-02-9 |
| Mol.F. | C13H7N3O3S |
| Mol.Wt. | 285.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Febuxostat Impurity 47 is chemically 2-(3,5-Dicyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid. Febuxostat Impurity 47 is supplied with detailed characterization data compliant with regulatory guideline. Febuxostat Impurity 47 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Febuxostat.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2407762-02-9
Purchase 2407762-02-9
Order 2407762-02-9
Enquire 2407762-02-9
price of 2407762-02-9
2407762-02-9 Supplier
2407762-02-9 Manufacturer
2407762-02-9 Exporter
buy high quality Febuxostat Impurity 47
Purchase Febuxostat Impurity 47
Febuxostat Impurity 47 suppliers
Febuxostat Impurity 47 manufacturers
Febuxostat Impurity 47 price
Order Febuxostat Impurity 47
Enquire Febuxostat Impurity 47
Febuxostat Impurity 47 cost
Febuxostat Impurity 47 Supplier
Febuxostat Impurity 47 Distributor
Febuxostat Impurity 47 for Method Validation
Febuxostat Reference Standard
Febuxostat Impurity 47 for ANDA Filing
Febuxostat Impurity 47 for Forced Degradation Studies
Febuxostat Impurity 47 Identification Standards
Febuxostat Impurity 47 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.